Rembrandt Grant worth 250,000 euros for Annette Neele (Amsterdam UMC) and Sander Kooijman (Leiden UMC)

The Rembrandt grant is a grant to simulate collaboration between cardiovascular researchers from Amsterdam UMC and Leiden UMC. Each grant covers a position for a PhD-student (worth 250.000 euros) who will be working at both the LUMC and Amsterdam UMC side.

Dr. Annette Neele (Inflammatory Diseases program, Amsterdam UMC): “With this grant we will aim to define the molecular mechanisms by which DHCR24 inhibition impacts on immune cell function by increasing endogenous desmosterol levels and study how this affects atherosclerosis”.

The research project of Annette and Sander is officially titled: Inhibition of dehydrocholesterol reductase 24 (DHCR24) as a novel strategy to combat atherosclerotic cardiovascular disease.

Dr. Annette Neele and Dr. Sander Kooijman received the Rembrandt award during the 13th Rembrandt Symposium. You can read more about this event here.

Read more about the grants recently awarded to our AII researchers:

Grant awarded: clinical trial anti-inflammatory drug for Sjögren's syndrome (October 2022)
AII collaboration grant in 2020, ENW-M NWO grant in 2022: the story of Nicole and Coen (October 2022)
Marieke Fransen receives KWF funding for fundamental lung cancer research (September 2022)

Amsterdam institute for Immunology and Infectious diseases

Rembrandt Grant worth 250,000 euros for Annette Neele (Amsterdam UMC) and Sander Kooijman (Leiden UMC)